Recruiting
Phase 2

Ultraviolet Light Therapy

Sponsor:

National Center for Research Resources (NCRR)

Code:

NCT00004375

Conditions

Systemic Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 15 - 70

Healthy Volunteers: Accepted

Interventions

ultraviolet A-1 light treatment

Study Details

Brief summary:

OBJECTIVES:

I. Evaluate the mechanisms of ultraviolet A-1 light therapy in patients with systemic lupus erythematosus and normal controls.

Conditions

Systemic Lupus Erythematosus

Study ID

NCT00004375

Start date

Sep, 1991

Status verified date

Jan, 2004

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 15 - 70

Healthy Volunteers: Accepted

PROTOCOL ENTRY CRITERIA:

--Disease Characteristics--

Patients ages 15 to 70 with symptomatic systemic lupus erythematosus meeting American Rheumatism Association criteria and normal controls

--Prior/Concurrent Therapy--

No requirement for tetracycline or other photosensitizing drugs

Study Design

Enrollment

20 participants

Primary purpose

Treatment

Interventions and Outcome Measures

Interventions

ultraviolet A-1 light treatment

Central Contacts and Locations

Locations

General Clinical Research Center and Charity Hospital (University of Louisiana)

Recruiting

New Orleans, Louisiana, United States, 70112-2822

Contacts

Hugh McGrath, Jr.

504-568-4630hmcgra@lsuhsc.edu

Alton Ochsner Medical Foundation Hospital

Recruiting

New Orleans, Louisiana, United States, 70121

Contacts

Jawed Alam

504-842-3314

More Information

Sponsor

National Center for Research Resources (NCRR)

Last update posted

Jun 24, 2005

Last verified

Jan, 2004

Keywords

  • arthritis & connective tissue diseases
  • immunologic disorders and infectious disorders
  • rare disease
  • systemic lupus erythematosus

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by National Center for Research Resources (NCRR) on 2005-06-24.